Takami Sato
Overview
Explore the profile of Takami Sato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
2157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Tanaka R, Mizue Terai , Londin E, Sato T
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771620
Hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (MET) signaling promotes tumorigenesis and tumor progression in various types of cancer, including uveal melanoma (UM). The roles of HGF/MET signaling have been studied...
22.
Slingluff C, Lewis K, Andtbacka R, Hyngstrom J, Milhem M, Markovic S, et al.
J Immunother Cancer
. 2021 Oct;
9(10).
PMID: 34599031
Background: Most patients with advanced melanomas relapse after checkpoint blockade therapy. Thus, immunotherapies are needed that can be applied safely early, in the adjuvant setting. Seviprotimut-L is a vaccine containing...
23.
Paradis J, Acosta M, Saddawi-Konefka R, Kishore A, Lubrano S, Gomes F, et al.
Clin Cancer Res
. 2021 Aug;
27(16):4664.
PMID: 34389658
No abstract available.
24.
Anikeeva N, Panteleev S, Mazzanti N, Mizue Terai , Sato T, Sykulev Y
J Biol Chem
. 2021 Aug;
297(3):101033.
PMID: 34371020
Although CAR-T cells are widely used to treat cancer, efficiency of CAR-T cell cytolytic responses has not been carefully examined. We engineered CAR specific for HMW-MAA (high-molecular-weight melanoma-associated antigen) and...
25.
Mizue Terai , Kageyama K, Sugase T, Lam B, Alexeev V, Sato T
Curr Protoc
. 2021 Apr;
1(4):e110.
PMID: 33882197
The propensity of uveal melanoma to metastasize to the liver hinders the accrual of micro-metastatic and end-stage disease tissue samples and restricts the investigation of metastatic uveal melanoma (MUM). Pre-clinical...
26.
Ohara M, Saito K, Kageyama K, Mizue Terai , Cheng H, Aplin A, et al.
Cancers (Basel)
. 2021 Apr;
13(5).
PMID: 33806615
Uveal melanoma (UM) is the most common cancer of the eye in adults. Up to 50% of UM patients subsequently develop metastases, especially in the liver. It has been reported...
27.
Baba H, Kanamori H, Katsumi M, Sato T, Chida T, Ikeda S, et al.
J Travel Med
. 2021 Mar;
28(6).
PMID: 33763694
No abstract available.
28.
Paradis J, Acosta M, Saddawi-Konefka R, Kishore A, Gomes F, Arang N, et al.
Clin Cancer Res
. 2021 Feb;
27(11):3190-3200.
PMID: 33568347
Purpose: Uveal melanoma is the most common eye cancer in adults. Approximately 50% of patients with uveal melanoma develop metastatic uveal melanoma (mUM) in the liver, even after successful treatment...
29.
Han A, Purwin T, Bechtel N, Liao C, Chua V, Seifert E, et al.
Oncogene
. 2021 Jan;
40(9):1753.
PMID: 33510355
No abstract available.
30.
Han A, Purwin T, Bechtel N, Liao C, Chua V, Seifert E, et al.
Oncogene
. 2020 Nov;
40(3):618-632.
PMID: 33208912
Cancer cell metabolism is a targetable vulnerability; however, a precise understanding of metabolic heterogeneity is required. Inactivating mutations in BRCA1-associated protein 1 (BAP1) are associated with metastasis in uveal melanoma...